<html>
<head>PUBMED IDs for CDCA3</head>
<body bgcolor='#C5F0F2'><h1>CDCA3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22839099/'>Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.</a> December 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24174975/'>Identification of Target Genes Involved in the Antiproliferative Effect of Enzyme-Modified Ginseng Extract in HepG2 Hepatocarcinoma Cell.</a> November 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25673160/'>OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.</a> January 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28487093/'>Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer.</a> May 11  2017<br></body></html>
